Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo.
Dernovšek J, Urbančič D, Zajec Ž, Sturtzel C, Grissenberger S, Wenninger-Weinzierl A, Gedgaudas M, Zubrienė A, Goričan T, Golič Grdadolnik S, Skok Ž, Ilaš J, Distel M, Zidar N, Tomašič T. Dernovšek J, et al. Among authors: tomasic t. Bioorg Chem. 2024 Oct 1;153:107850. doi: 10.1016/j.bioorg.2024.107850. Online ahead of print. Bioorg Chem. 2024. PMID: 39395321 Free article.
Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency.
Dernovšek J, Zajec Ž, Poje G, Urbančič D, Sturtzel C, Goričan T, Grissenberger S, Ciura K, Woziński M, Gedgaudas M, Zubrienė A, Grdadolnik SG, Mlinarič-Raščan I, Rajić Z, Cotman AE, Zidar N, Distel M, Tomašič T. Dernovšek J, et al. Among authors: tomasic t. Biomed Pharmacother. 2024 Aug;177:116941. doi: 10.1016/j.biopha.2024.116941. Epub 2024 Jun 17. Biomed Pharmacother. 2024. PMID: 38889640 Free article.
Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders.
Dernovšek J, Goričan T, Gedgaudas M, Zajec Ž, Urbančič D, Jug A, Skok Ž, Sturtzel C, Distel M, Grdadolnik SG, Babu K, Panchamatia A, Stachowski TR, Fischer M, Ilaš J, Zubrienė A, Matulis D, Zidar N, Tomašič T. Dernovšek J, et al. Among authors: tomasic t. Eur J Med Chem. 2024 Oct 5;280:116934. doi: 10.1016/j.ejmech.2024.116934. Online ahead of print. Eur J Med Chem. 2024. PMID: 39388906 Free article.
Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.
Keček Plešec K, Urbančič D, Gobec M, Pekošak A, Tomašič T, Anderluh M, Mlinarič-Raščan I, Jakopin Ž. Keček Plešec K, et al. Among authors: tomasic t. Bioorg Med Chem. 2016 Nov 1;24(21):5221-5234. doi: 10.1016/j.bmc.2016.08.044. Epub 2016 Aug 24. Bioorg Med Chem. 2016. PMID: 27601373
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
Durcik M, Nyerges Á, Skok Ž, Skledar DG, Trontelj J, Zidar N, Ilaš J, Zega A, Cruz CD, Tammela P, Welin M, Kimbung YR, Focht D, Benek O, Révész T, Draskovits G, Szili PÉ, Daruka L, Pál C, Kikelj D, Mašič LP, Tomašič T. Durcik M, et al. Among authors: tomasic t. Eur J Med Chem. 2021 Mar 5;213:113200. doi: 10.1016/j.ejmech.2021.113200. Epub 2021 Jan 22. Eur J Med Chem. 2021. PMID: 33524686
128 results